The people behind UltraVision

Charles Scott

Charles holds a degree in computational science from the University of Central Florida and has been with the company since 2007. He is the architect of UltraVision's imaging algorithms and directly responsible for the system's image quality, and he is the inventor of the patented method of imaging microcalcifications behind MC-mode (U.S. Patent 12,773,182).

His work spans GPU development, driver integration and PCB design, and he serves as the primary technical liaison with customers. charles@ultravisionusa.com

Lee A. Fox, MD

Dr. Fox is Chief of Staff at Jupiter Medical Center in Jupiter, Florida, and is board-certified in diagnostic radiology, vascular and interventional radiology, and phlebology. He earned his medical degree at Washington University in St. Louis and completed his residency in diagnostic radiology at Brigham and Women's Hospital, Harvard Medical School.

At UltraVision he brings the practicing radiologist's view to the clinical program, from point-of-care imaging to the MC-mode breast screening work.

Guy Scott

Guy began his career in ultrasound in 1975 selling the Searle B-scanner in Australasia, developed a radiotherapy planning system inside the scanner's PDP-11, and after Siemens acquired the company became its ultrasound product line manager. In 1981 he founded Pie Data Medical, then the Probe Corporation for urology and veterinary ultrasound, and in 1996 Cross Match Technologies, whose fingerprint systems were used at more than 10,000 U.S. customs stations and became the first ten-print system approved by the FBI at 500 dpi; Cross Match was later sold for $240 million.

He then founded WinProbe to build cost-effective, PC-based ultrasound systems, the vision that became UltraVision, securing ten NIH grants for transducer, beamformer, correlator and user-interface innovation along the way. Today he conducts due diligence and selected research as Executive Strategy Officer.

Frank Gerardi

After serving in the United States Army, Frank became the youngest member of the New York Stock Exchange at 24 and remained a member for 17 years. He continued his education at the New York Institute of Finance, became an NASD principal and founded Univest Management, which has consulted on the tax-free spin-off of a public company and for biotech and financial institutions. He is a former Executive Vice President of Lehman Brothers, Boston.

Frank has served on private and public boards. As Chairman and CEO of IGI Labs he negotiated contracts with Estee Lauder and Chattem and led the company's transformation from contract cosmetic manufacturing to an FDA-approved topical generic pharmaceutical company. As audit committee chairman of Dyadic International he helped negotiate the sale of one of its businesses to DuPont for $75 million.

James Davis Jr.

A manufacturing engineer who learned the trade in his father's machine shop, James joined Cordis Corporation, the cardiac pacemaker and catheter maker, where he was supervising tool design at 24 and running a 170-person plant at 26. He went on to found Micro Med Machining, growing it to $25 million in revenue before its sale, and the dental implant company ImplaMed, also sold to a strategic buyer.

With his brother and father he then built 3D Medical Manufacturing, doubling it through organic growth and acquisition with private equity partners Scorpion Capital and Genstar Capital before its sale to Charlesbank for $4.5 billion. The business continues today as Tecomet.

Eric Kraus

Eric is the principal of Kimball Road Strategies, a marketing, communications and public affairs consultancy, and the former chief communications officer at Gillette, Covidien, Bacardi and Clean Harbors. At Covidien he oversaw the spin-off of Tyco International's health care division and the creation of the Covidien brand; at Procter & Gamble, following its merger with Gillette, he had worldwide responsibility for communications and public affairs.

Over his career he has handled more than 7,500 media interviews, led crisis and issues management for more than 20 years, and managed more than 140 agencies worldwide. He is a graduate of Boston University.

Paul Papi

Paul is the principal of Outreach99 LLC, a marketing and investor relations firm that bridges early-stage life science companies and their investors and markets. He was previously a licensed Series 7 and 63 investment banker helping young companies raise early-stage financing and pursue mergers and acquisitions.

Before that he spent 29 years in leadership roles across three divisions of Mylan Labs, now part of Pfizer.

Robert D. Burke, MD

Dr. Burke is a board-certified diagnostic radiologist with subspecialties in neuroradiology and head and neck radiology. He is the owner and managing radiologist of Advanced Diagnostic Group, a six-center outpatient imaging business, and provides teleradiology services in neuro and musculoskeletal imaging. He founded Midtown Imaging in 1991 and grew it to six facilities across Palm Beach County with $50 million in annual revenue before its sale in 2008, and co-founded U.S. Diagnostics, which he took public in 1994 and which operated 120 imaging facilities nationally.

He trained at the University of Louisville School of Medicine, the University of Chicago's Michael Reese Medical Center and the University of Rochester, and was chairman of radiology at Wellington Regional Medical Center.

Charles Scott and Guy Scott

The company's Chief Executive Officer and its founder also serve on the board. Their biographies are above.